Abstract. The stability of oligodeoxynucleotides to trifluoroacetic acid is studied.
Introduction. The use of synthetic oligonucleotides to control gene expression has triggered the search for new oligonucleotide derivatives with improved therapeutic potential [1] . Oligonucleotide-peptide conjugates are chimeric molecules consisting of oligonucleotides covalently linked to peptides. As a result, synthetic oligonucleotides acquire some of the biological and/or biophysical properties of peptides. Two strategies can be followed to synthesize oligonucleotide-peptide conjugates [2] . In the post-synthetic conjugation approach, the two moieties are prepared independently and specific groups (such as thiols and maleimido) are specifically incorporated to link both molecules [3] . In the stepwise approach, oligonucleotide-peptide conjugates are prepared by stepwise addition of amino acids and phosphoramidites in solid phase on the same solid support [4] . In this case, the problem is the incompatibility of the standard schemes of protection for peptides and oligonucleotides. For example, at the end of the solid-phase peptide synthesis, a treatment with acid is usually required, which can provoke partial depurination of DNA.
Recently, our group has undertaken the preparation of conjugates consisting of doublestranded DNA (dsDNA) and selected fragments of biologically relevant transcription factors. Specifically we focused on the synthesis of conjugates between DNA and peptidic regions from the leucine zipper domain of FOS [5] . These constructs, which display a dual recognition surface provided by the presence of both the peptide and the DNA, were devised as potential specific receptors for selected FOS partners, such as the well known oncogenic transcription factor JUN. Hypothetically, the recognition would involve a specific interaction between the leucine-rich region of JUN and the hybrid, and an additional interaction between the oligonucleotide portion of the constructs and the basic region of JUN [6] . The synthesis of these conjugates is difficult due to the presence of long peptide sequences with large number of trifunctional amino acids. In any case we evaluated the viability of making this type of oligonucleotidepeptide conjugates using a stepwise Fmoc, t-butyl strategy.
Results and Discussion.
Stability of oligodeoxynucleotides to trifluoroacetic acid. Trifluoroacetic acid (TFA) is a strong acid commonly used in the final deprotection step of peptide synthesis using Fmoc-amino acids. It is known that acidic solutions provoke depurination of purine nucleosides. On the other hand, depurination is slower in oligonucleotides and indeed several experiments on the use of TFA to remove Boc groups in the presence of oligodeoxynucleotides were described almost two decades ago [7, 8] . In order to study the extension of this reaction we have treated 4 oligodeoxynucleotide sequences (T 9 , T 4 CT 4 , T 4 AT 4 and T 4 GT 4 ) with 95% TFA aqueous solution. Two different treatments were studied. Treatment A: The oligonucleotide supports (polystyrene, LV200) obtained after the assembly of the oligonucleotide sequence still carrying the protecting groups were treated with 95% TFA aqueous solution. After 2 hours, the acidic solution was filtered out and the support was treated with concentrated ammonia. The resulting solution was concentrated to dryness and analyzed by reversed-phase HPLC. Treatment B:
Oligonucleotides were deprotected with ammonia and the resulting unprotected oligonucleotides were treated with 95% TFA aqueous solution for 2 hours. The resulting solutions were concentrated to dryness, treated with ammonia (to break apurinic sites) and analyzed by HPLC.
Pyrimidine oligonucleotides (T 9 and T 4 CT 4 ), after treatment A, gave a single peak with the expected mass by MALDI MS, indicating stability of the oligonucleotides to the TFA treatment as it is expected due to the higher stability of the glycosidic bond of pyrimidine nucleosides. Exceptionally, treatment B on T 4 CT 4 with TFA promoted a slight decomposition. Oligonucleotide sequence carrying adenine (T 4 AT 4 ) gave two more peaks eluting before the peak of the initial oligonucleotide (Figure 1 ). This indicates loss of the adenine followed by hydrolysis of phosphate at the abasic site by ammonia. The extension of the depurination was around 80% in treatment A and 60% in treatment B. Oligonucleotide sequence carrying guanine (T 4 GT 4 ) was stable to treatment A but unstable to treatment B (30% depurination). This is consistent with the higher stability of dG to depurination compared to dA. Depurination was more severe in The synthesis of the 35 amino acid peptide was carried out manually on a Rink-MBHA amide resin using Fmoc-protected amino acids and a symmetric anhydride strategy. In order to incorporate the oligonucleotide sequence to the peptide support, the amino terminal group was reacted with the O-4-trityl derivative of 4-hydroxybutanoic acid. This compound will generate the hydroxyl group which will be used to assemble the oligonucleotide sequence (Scheme 1). Figure 2 Figure 1 . HPLC of the mixture resulting from the treatment of the support carrying T 4 AT 4 followed by ammonia deprotection. The late-eluting peak is the remaining fulllength oligonucleotide sequence T 4 AT 4 . HPLC conditions as follows. Nucleosil 120 C18 (250 x 8 mmm) column at a flow rate of 3 mL/min, detection 260 nm, gradient 0-50% B in 20 min, A: 5% CH 3 CN in 100 mM triethylammonium acetate (TEAA) pH 7.0, B: 70% CH 3 CN in 100 mM TEAA pH 7.0. 
